SB

Swatantr Bahadur Singh

Active Director Director DIN 11410667
DIN 11410667 First appointment Dec 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Swatantr Bahadur Singh

Data last updated:

Swatantr Bahadur Singh is a Director at Ifcare Pharma Private Limited (since 2025).

DIN 11410667
Primary Designation Director
First Appointment 05 Dec 2025

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ifcare Pharma Private Limited U21000UP2025PTC237641
Director05 Dec 20252025Active

Board colleagues of Swatantr Bahadur Singh

NameDINCompanyDesignation
Sukirti Upadhyay11410666Ifcare Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Ifcare Pharma Private Limited
Premium access

Shareholding and investment profile for Swatantr Bahadur Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Swatantr Bahadur Singh

Swatantr Bahadur Singh currently holds 1 directorship: Ifcare Pharma Private Limited (Director, since 05 Dec 2025).

Swatantr Bahadur Singh was first appointed on 05 Dec 2025 as Director at Ifcare Pharma Private Limited.

The current boards of Swatantr Bahadur Singh's companies include Sukirti Upadhyay (Ifcare Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available